Literature DB >> 19880317

COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans.

Ericsson David Coy1, Luis Enrique Cuca, Michael Sefkow.   

Abstract

The anti-inflammatory potential of 26 neolignans (14 of the bicyclooctane-type and 12 of the benzofuran-type), isolated from three Lauraceae species (Pleurothyrium cinereum, Ocotea macrophylla and Nectandra amazonum), was evaluated in vitro through inhibition of COX-1, COX-2, 5-LOX and agonist-induced aggregation of rabbit platelets. Benzofuran neolignans were found to be selective COX-2 inhibitors, whereas bicyclooctane neolignans inhibit selectively the PAF-action as well as COX-1 and 5-LOX. The neolignan 9-nor-7,8-dehydro-isolicarin B 15 and cinerin C 7 were found to be the most potent COX-2 inhibitor and PAF-antagonist, respectively. Nectamazin C 10 exhibited dual 5-LOX/COX-2 inhibition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880317     DOI: 10.1016/j.bmcl.2009.10.069

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Photocatalytic synthesis of dihydrobenzofurans by oxidative [3+2] cycloaddition of phenols.

Authors:  Travis R Blum; Ye Zhu; Sarah A Nordeen; Tehshik P Yoon
Journal:  Angew Chem Int Ed Engl       Date:  2014-08-25       Impact factor: 15.336

2.  LOX inhibitor HOEC interfered arachidonic acid metabolic flux in collagen-induced arthritis rats.

Authors:  Wen Yang; Xia Wang; Liuxin Xu; Honglin Li; Rui Wang
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

3.  Intramolecular radical cyclization approach to access highly substituted indolines and 2,3-dihydrobenzofurans under visible-light.

Authors:  Clarice A D Caiuby; Akbar Ali; Vinicius T Santana; Francisco W de S Lucas; Marilia S Santos; Arlene G Corrêa; Otaciro R Nascimento; Hao Jiang; Márcio W Paixão
Journal:  RSC Adv       Date:  2018-04-05       Impact factor: 4.036

Review 4.  Natural Products for Antithrombosis.

Authors:  Cen Chen; Feng-Qing Yang; Qian Zhang; Feng-Qin Wang; Yuan-Jia Hu; Zhi-Ning Xia
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

Review 5.  Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.

Authors:  Mohamed S Abdel-Bakky; Elham Amin; Mohamed G Ewees; Nesreen I Mahmoud; Hamdoon A Mohammed; Waleed M Altowayan; Ahmed A H Abdellatif
Journal:  Viruses       Date:  2022-01-24       Impact factor: 5.048

6.  Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity.

Authors:  Ericsson Coy-Barrera
Journal:  Biomolecules       Date:  2020-01-23

7.  Covalent Triazine Framework Nanoparticles via Size-Controllable Confinement Synthesis for Enhanced Visible-Light Photoredox Catalysis.

Authors:  Wei Huang; Niklas Huber; Shuai Jiang; Katharina Landfester; Kai A I Zhang
Journal:  Angew Chem Int Ed Engl       Date:  2020-09-21       Impact factor: 16.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.